🔗 Permalink

Assignee profile:

Molecular Partners AG

City:

Schlieren

Country:

Switzerland

Published Applications:

Last publication date:

2024-04-18

Patent Grants:

Last grant date:

2025-10-14

Top Inventors for applications by Molecular Partners AG

These are the the leading inventors for applications assigned to Molecular Partners AG:

Hans Kaspar Binz 12 Birmensdorf, Switzerland
Patrik Forrer 7 Dietikon, Switzerland
Douglas Phillips 6 Baden, Switzerland
Frieder W. Merz 6 Mellingen, Switzerland

Maya Gulotti-Georgieva 5 Wettswil a.A., Switzerland
Daniel Steiner 5 Zurich, Switzerland
Ivo Sonderegger 5 Urdorf, Switzerland
Michael Tobias Stumpp 4 Geroldswil, Switzerland

Talitha BAKKER 4 Birmensdorf, Switzerland
Johan ABRAM SALIBA 3 Lausanne, Switzerland
Michael T. STUMPP 3 Geroldswil, Switzerland
Ignacio Dolado 3 Rheinfelden, Switzerland

Marcel WALSER 1 Schlieren, Switzerland
Victor Levitsky 1 Schlieren, Switzerland
Christian REICHEN 1 Schlieren, Switzerland
Sebastian GRIMM 1 Schlieren, Switzerland

Matteo BIANCHI 1 Schlieren, Switzerland
Gaby TRESCH 1 Wolfhausen, Switzerland
Nina RESCHKE 1 Schlieren, Switzerland
Kaspar H. BINZ 1 Birmensdorf, Switzerland

Bernd SCHLERETH 1 Schlieren, Switzerland
Johannes SCHILLING 1 Schlieren, Switzerland
Michael BAUMANN 1 WINTERTHUR, Switzerland

Recent patent applications by Molecular Partners AG

Molecular Partners AG based in Schlieren, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-04-18 ✅ Patent 12,441,772 granted on 2025-10-14

US20240124535A1

Chemistry; metallurgy

DESIGNED ANKYRIN REPEAT DOMAIN WITH IMPROVED STABILITY

#2 | 2023-02-23 ✅ Patent 11,834,504 granted on 2023-12-05

US20230056271A1

Chemistry; metallurgy

DARPin based multi-specific t-cell engagers

#3 | 2019-08-29 ✅ Patent 11,332,501 granted on 2022-05-17

US20190263869A1

Chemistry; metallurgy

Recombinant binding proteins and their use

#4 | 2018-05-10 ✅ Patent 10,646,542 granted on 2020-05-12

US20180125932A1

Human necessities

Modified binding proteins inhibiting the VEGF-A receptor interaction

#5 | 2017-11-02 ✅ Patent 10,322,190 granted on 2019-06-18

US20170313748A1

Chemistry; metallurgy

Capping modules for designed ankyrin repeat proteins

#6 | 2016-12-15 ✅ Patent 10,155,791 granted on 2018-12-18

US20160362453A1

Chemistry; metallurgy

Recombinant binding proteins and their use

#7 | 2016-10-06 ✅ Patent 9,458,211 granted on 2016-10-04

US20160289285A1

Chemistry; metallurgy

Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

#8 | 2016-09-15 ✅ Patent 9,849,158 granted on 2017-12-26

US20160263185A1

Human necessities

Modified binding proteins inhibiting the VEGF-A receptor interaction

#9 | 2016-09-01 ✅ Patent 11,453,708 granted on 2022-09-27

US20160251404A1

Chemistry; metallurgy

Designed ankyrin repeat proteins binding to hepatocyte growth factor

#10 | 2016-09-01 ✅ Patent 9,775,912 granted on 2017-10-03

US20160250341A1

Human necessities

Designed repeat proteins binding to serum albumin

#11 | 2016-03-17 ✅ Patent 9,717,802 granted on 2017-08-01

US20160075767A1

Chemistry; metallurgy

Capping modules for designed ankyrin repeat proteins

#12 | 2014-08-07 ✅ Patent 9,289,466 granted on 2016-03-22

US20140221295A1

Human necessities

Modified binding proteins inhibiting the VEGF-A receptor interaction

#13 | 2014-01-02 ✅ Patent 9,163,070 granted on 2015-10-20

US20140005125A1

Chemistry; metallurgy

Designed ankyrin repeat proteins binding to platelet-derived growth factor

#14 | 2013-11-07 ✅ Patent 9,221,892 granted on 2015-12-29

US20130296221A1

Chemistry; metallurgy

Capping modules for designed ankyrin repeat proteins

#15 | 2013-09-19 ✅ Patent 9,284,361 granted on 2016-03-15

US20130244940A1

Chemistry; metallurgy

Designed repeat proteins binding to serum albumin

#16 | 2013-05-09 ✅ Patent 8,710,187 granted on 2014-04-29

US20130116197A1

Chemistry; metallurgy

Modified binding proteins inhibiting the VEGF-A receptor interaction

Also check out Molecular Partners AG's (Schlieren, Switzerland) applicant profile with 17 patent applications submitted.

AssigneeID:

39593 ⎘